Skip to main content
Download PDF

Effect of low sodium and high potassium diet on lowering blood pressure and cardiovascular events

Clinical Hypertension volume 30, Article number: 2 (2024) Cite this article

Abstract

Incorporating aggressive lifestyle modifications along with antihypertensive medication therapy is a crucial treatment strategy to enhance the control rate of hypertension. Dietary modification is one of the important lifestyle interventions for hypertension, and it has been proven to have a clear effect. Among food ingredients, sodium and potassium have been found to have the strongest association with blood pressure. The blood pressure-lowering effect of a low sodium diet and a high potassium diet has been well established, especially in hypertensive population. A high intake of potassium, a key component of the Dietary Approaches to Stop Hypertension (DASH) diet, has also shown a favorable impact on the risk of cardiovascular events. Additionally, research conducted with robust measurement methods has shown cardiovascular benefits of low-sodium intake. In this review, we aim to discuss the evidence regarding the relationship between the low sodium and high potassium diet and blood pressure and cardiovascular events.

Graphical Abstract

Background

Hypertension is a major risk factor for cardiovascular events and deaths worldwide [1]. Despite the improvement in treatment strategies, including medications for hypertension, the control rate of hypertension has not reached 50% and remains an unmet challenge for public health [2, 3]. Implementing aggressive lifestyle modifications in addition to antihypertensive medication therapy is a very important treatment strategy for improving the control rate of hypertension [4, 5]. Dietary modification is one of the important lifestyle interventions for hypertension, and it has been proven to have a clear effect. Sodium and potassium are the most closely related elements to blood pressure among food ingredients [5]. Sodium is the ion with the highest concentration in extracellular fluid and determines the oncotic pressure of extracellular fluid, whereas potassium is the ion with the highest concentration inside cells and can indirectly affect blood pressure by participating in the renal excretion of sodium rather than directly regulating blood pressure [6]. As the population ages and the number of obese individuals continues to increase, the importance of dietary modification in blood pressure control is expected to increase [7].

Therefore, this paper aims to review the blood pressure-lowering effect of low sodium and high potassium diets and the latest clinical applications. “Salt” usually refers to sodium chloride, but for clarity in this paper, the term “sodium” is used uniformly except for specific terms. From the perspective of ion concentration between intracellular and extracellular fluid, the ion concentration of extracellular fluid is a more accurate expression than that of plasma ion concentration. However, since there is no significant difference in ion concentration between extracellular fluid and plasma, this paper considers that the concentration of ions without additional modifiers refers to the ion concentration in both extracellular fluid and plasma.

Effects of sodium on blood pressure

Sodium, extracellular fluid balance, and blood pressure

Sodium is an element that forms the highest concentration in extracellular fluid, and it exists in the form of sodium cations in body fluids, determining the osmotic pressure of extracellular fluid [7]. A constant osmotic pressure of extracellular fluid is an essential element for the survival, and in clinical practice, it is maintained steadily as long as water intake and excretion are not disrupted. If observed in very short time period, an increase in sodium intake may cause an increase in the osmotic pressure of the extracellular fluid and the phenomenon of the osmoreceptor cells in the intracellular fluid being stimulated by the movement of water out of the cells, causing thirst. However, this process is a dynamic process, and changes in osmotic pressure can only be observed as an increase in extracellular fluid, and it is difficult to observe an actual increase in sodium concentration [8]. Therefore, when sodium is consumed, only extracellular fluid increases without change in sodium concentration, meaning that sodium intake implies an increase in extracellular fluid. Conversely, decreasing sodium intake means decreasing extracellular fluid.

In the human body, the extracellular fluid is divided into two compartments: the interstitial fluid, which constitutes about 3/4 of the extracellular fluid, and the intravascular fluid, that is plasma volume, which constitutes about 1/4 of the extracellular fluid. Approximately every 3 hours, extracellular fluid is completely circulated once, and in this exchange process, about 180 L of kidney filtration is possible every day [9]. The human kidney is comprised of over a million functional units called nephrons. Blood enters the kidney through the afferent arteriole and is filtered in a network of small blood vessels known as the glomerulus, which deposits the filtrate into Bowman’s capsule - the initial component of the nephron. The glomerular filtrate then passes through the proximal tubule, the loop of Henle (with its descending and ascending limbs), the distal tubule, and the collecting duct. Approximately 65% of the sodium that enters the nephrons is reabsorbed from the renal tubules into the interstitial fluid and then into the general circulation through peritubular capillaries. The ascending limb of the loop of Henle actively secretes sodium into the interstitial space but is impermeable to water, resulting in the interstitial space between the ascending and descending limbs being hypertonic. This hypertonicity establishes an osmotic gradient between the fluid within the descending limb and the interstitial space, which removes water from the descending limb and increases the fluid tonicity within it. As the ascending limb is impermeable to water, sodium continues to be actively pumped out. Thus, the kidney is specialized according to the location, allowing for fine control of water and sodium through differentiation of sodium concentration depending on the location [10,11,12]. The rate of natriuresis depends on the ratio between the glomerular filtration rate, sodium tubular reabsorption, and secretion of the fluid containing sodium into the nephron tubular lumen [13].

As sodium intake increases, extracellular fluid volume increases, and intravascular volume increases in proportion. As a result, cardiac output increases, leading to a subsequent increase in blood pressure. The physiological mechanism by which an increase in BP in the renal arteries leads to an increased salt and water excretion is called pressure natriuresis [14].

Salt sensitivity and blood pressure

In human body, the efficiency of sodium excretion in response to an increase in blood pressure varies greatly from individual to individual. For example, if there is a slight increase in blood pressure due to an increase in extracellular fluid, but if the excess fluid is immediately excreted through the kidneys and blood pressure returns to normal, it may appear in a clinical setting that blood pressure does not increase even with high sodium intake. On the other hand, if blood pressure slightly increases after an increase in extracellular fluid, and if the fluid or sodium cannot be excreted through the kidneys until a significantly high blood pressure is maintained, blood pressure will remain high until all the excess extracellular fluid is excreted after sodium intake. If the increased extracellular fluid is not normalized and another high sodium intake is consumed before blood pressure is fully recovered, blood pressure may continue to rise and be diagnosed as sustained blood pressure elevation. Thus, the degree of increase in blood pressure due to the increase in extracellular fluid following the intake of sodium or administration of sodium-containing fluids is defined as salt sensitivity [15].

In normal individuals, half of the ingested sodium is excreted within a day, and after 3–4 days, the total amount of sodium returns to its original level [16]. The degree of blood pressure elevation at this time is determined by individual salt sensitivity. The daily urinary sodium excretion slope (kNa, day−1) of 0.79 in normal individuals may decrease in the elderly and in patients with chronic kidney disease, which may result in a longer period for extracellular fluid to return to its original level than 3–4 days [6]. Therefore, if sodium is repeatedly ingested before recovery, patients with high salt sensitivity are at a higher risk of being diagnosed with hypertension [17]. The mechanisms that affect salt sensitivity include activation of the renin-angiotensin system, activation of the sympathetic nervous system, dysfunction of the renal sodium channel, and impaired endothelial cell function [18]. In clinical practice, important conditions related to salt sensitivity include aging, chronic kidney disease, and metabolic disorders including abdominal obesity that are closely related to these mechanisms [19].

Sodium in human tissues

One of the mechanisms explaining salt sensitivity is that if the sodium consumed is present in a concentrated form in the extracellular fluid, even salt-sensitive patients may experience a significant temporal delay in the rise of blood pressure until the point at which the sodium storage capacity is reached, despite sodium intake. Until recently, it has been reported that sodium present in the skin or muscle can exist in a concentrated form, separate from the principle of osmotic pressure, to enable this buffering action [20]. However, some recent studies have also reported that the osmotic pressure of sodium present in the skin is not higher than that of the extracellular fluid, suggesting that the high concentration of sodium in the skin may be reflecting only subclinical tissue edema [21].

Effects of potassium on blood pressure

Regulation of potassium balance

Potassium is an electrolyte unrelated to osmotic pressure, and unlike sodium, there is no immediate mechanism to maintain the concentration of extracellular fluid. The amount of potassium intake through food and the amount excreted through the kidneys, gastrointestinal tract, sweat, etc. determine balance state. Therefore, under same excretion conditions, the amount of potassium consumed through food can have an impact on the potassium concentration of extracellular fluid [22, 23].

Effect of potassium on sodium balance

The intake of potassium has been reported to lower blood pressure in both human and animal models, and it is particularly effective when salt sensitivity is high or sodium intake is high [24, 25]. The aldosterone-sensitive distal nephron (ASDN) is responsible for the hormone-regulated unidirectional sodium transport and bidirectional potassium transport [26,27,28]. The ASDN consists of the late one-third of distal convoluted tubule (DCT2), the connecting tubule (CNT), and the cortical collecting duct (CCD). In the early two-thirds of the DCT (DCT1), the apical sodium-chloride cotransporter (NCC) is the major sodium transporter, which mediates electroneutral sodium reabsorption. In DCT2, NCC is co-expressed with the epithelial sodium channel (ENaC) and the renal outer medullary K+ (ROMK) channel [29, 30]. The main apical transporter responsible for electrogenic Na + reabsorption in the ASDN is ENaC [31]. The ENaC transporter orchestrates predominant electrogenic Na + reabsorption in the ASDN, generating a lumen-negative transepithelial voltage that ultimately plays a pivotal role in driving potassium secretion via ROMK. In addition to ROMK, the ASDN also expresses big-K+ channels (BK channels), which play a crucial role in flow-dependent potassium secretion [32]. This allows the ASDN to switch between electroneutral sodium reabsorption (via NCC) and electrogenic sodium reabsorption (via ENaC), enabling adjustments in urinary potassium and sodium excretion in response to dietary changes (Fig. 1).

Fig. 1
figure 1

Overview of sodium and potassium handling in distal nephron

Full size image

Recent research indicates that the DCT acts as a potassium sensor and influences downstream potassium handling by regulating sodium delivery [33, 34]. In general, inward rectifier means hyperpolarization triggered potassium channel permit influx to stabilize the membrane potential. But in DCT, Kir4.1/Kir5.1 is the only potassium channel expressed on the basolateral membrane of the DCT so that it acts not as inward rectifier but as potassium leakage channel which is crucial in maintaining membrane potential [35]. It also has the role in detecting plasma potassium levels, and subsequently, modulating NCC activity [36]. Under conditions of low potassium diet, the potassium channel Kir4.1/Kir5.1 detects reduced extracellular potassium concentration, leading to potassium efflux through the basolateral plasma membrane of DCT cells [37, 38]. This process induces membrane hyperpolarization and stimulates chloride efflux [39]. The ensuing decrease in intracellular chloride concentration relieves the inhibition of chloride-sensitive kinases, especially with-no-lysine (K) kinases (WNKs), prompting autophosphorylation [40]. As a consequence, the activation of these phosphorylated WNKs triggers intermediate kinases such as Ste-20-related proline alanine-rich protein kinase (SPAK), which subsequently activate NCC, facilitating sodium reabsorption into the cell through NCC and leading to decreased natriuresis, kaliuresis, and elevated blood pressure (Fig. 2A) [41,42,43]. Salt-sensitive hypertension linked to NCC stimulation under low potassium intake [44]. Conversely, with a heightened potassium diet, Kir4.1/Kir5.1 channels are suppressed, leading to NCC dephosphorylation and diminished activity, subsequently decreasing sodium reabsorption. The suppression of NCC activity encourages kaliuresis while curbing sodium preservation, even in the face of heightened aldosterone levels. The kaliuretic effect resulting from dietary potassium intake actually precedes the rise in plasma aldosterone and is accompanied by natriuresis [3]. Moreover, due to the reduction in sodium reabsorption through NCC, there is an increased sodium delivery to the downstream ASDN. This intensifies the electrogenic sodium reabsorption mediated by ENaC, leading to the creation of an electrochemical gradient that propels the secretion of potassium through ROMK channels (Fig. 2B) [45,46,47]. Aldosterone plays a role in regulating urinary potassium excretion and sodium reabsorption by acting on the mineralocorticoid receptor at the late CNT and entire CCD and controlling the activity of genes involved in ENaC regulation [31, 48].

Fig. 2
figure 2

Role of the distal convoluted tubule as a potassium sensor regulating downstream potassium handling via sodium delivery in response to dietary potassium levels (A) effect of low potassium diet (B) effect of high potassium diet

Full size image

Dietary sodium affects NCC phosphorylation. High sodium intake restrains NCC phosphorylation, whereas low sodium intake stimulates it [49]. Despite high sodium intake, NCC activation due to a low potassium diet retains sodium, leading to elevated blood pressure. Conversely, under low sodium intake, a high potassium diet reduces NCC activity, even with activated systems [43, 50]. Jensen et al. noted that acute potassium loading prompts NCC dephosphorylation and natriuresis, regardless of sodium levels [45]. These findings emphasize prioritized potassium homeostasis over sodium regulation.

To conclude, the regulation of NCC activation is remarkably responsive to alterations in extracellular potassium levels [51, 52]. This sensitivity implies that even under conditions of elevated sodium intake, if extracellular potassium levels are also high, NCC activity is hindered, resulting in increased sodium excretion. This mechanism effectively counteracts blood pressure elevation, particularly beneficial for individuals with salt sensitivity increases in blood pressure [53, 54].

Benefit of low sodium diet

Recommendation of low sodium diet and issues related to interpretation of the evidence

There are many evidences that high sodium intake is associated with high blood pressure in both humans and animals [55,56,57]. Physiological requirements for sodium are < 500 mg/day in most healthy individuals, but currently usual sodium intake is between 3.5 and 5.5 g/day (which corresponds to 9–12 g of salt per day) in worldwide [58]. The World Health Organization (WHO) recommends a maximum daily intake of 2 g of dietary sodium (5 g of salt) for adults [59]. In addition, most countries and guidelines also suggest limiting intake to less than 2.0–2.4 g per day as part of a dietary approach to prevent high blood pressure and cardiovascular disease [5, 59,60,61,62]. Although there is general agreement regarding the reduction of dietary sodium intake in hypertensive patients and the general population, there are several issues related to the interpretation of the evidence supporting this approach. In the general population, there are claims that excessive restriction of sodium may not only have minimal benefits for lowering blood pressure, but may also increase blood cholesterol levels and the risk of mortality [63, 64]. On the other hand, some argue that a higher risk of mortality in low sodium intake group may be caused by reverse causality and estimation inaccuracy of sodium intake [65,66,67]. The other issues include whether there is repeated evaluation of sodium intake, the duration of the low sodium intervention period, and whether blood pressure reduction induced by sodium reduction is sustained or not [68,69,70].

Assessment of sodium intake

Accurately measuring dietary sodium intake is crucial in individual and public healthy, but obtaining an unbiased measurement of sodium intake is challenging. Nutritional assessment tools, such as questionnaires, food diaries, and diet recalls, are often used in large nutrition surveys. However, these tools often exhibit inaccuracies when measuring individual dietary sodium intake compared to the gold standard of 24-hour urinary sodium excretion [71, 72]. The 24-hour urinary sodium excretion is widely regarded as the most accurate method of measurement of dietary sodium intake. It reflects about 90% of the sodium ingested over a day [73]. However, the accuracy can be affected by both undercollection and overcollection, as well as the high variability of sodium intake in an individual between days. Therefore, multiple collections are required to obtain a reliable estimation [74]. To overcome the methodological challenges of collecting complete 24-hour urine samples in large population-based studies, alternative estimation methods using spot urine have been introduced. Methods like Kawasaki, Tanaka, and International Cooperative Study on Salt, Other Factors, and Blood Pressure (INTERSALT), which estimate 24-hour urinary sodium excretion, have gained popularity in population-based studies [75,76,77,78]. However, these methods are not suitable for estimating salt intake in individuals due to their unreliability and inherent systematic bias [79]. Spot urine samples can lead to overestimation when sodium intake is low and underestimation when sodium intake is high [80]. This has been consistently observed in validation studies conducted to date, including the PURE Study [65, 81].

Blood pressure-lowering effect of sodium restriction

Several studies restricting sodium intake have demonstrated a blood pressure-lowering effect. Recent meta-analyses have shown that effect of sodium reduction from an average high usual intake (4.6 g/day) to the recommended level (1.5 g/day) by the American Heart Association (AHA) was small in normotensive population (− 1.14/+ 0.01 mmHg in systolic/diastolic blood pressure). The effect of sodium reduction on blood pressure was pronounced decrease of − 5.71/− 2.87 mmHg in hypertensive population. The effect of sodium reduction was a little greater in Asian and black people than in white people [64]. In addition, the blood pressure-lowering effect of sodium reduction was more pronounced in patients with increased salt sensitivity, such as elderly, diabetic, metabolic syndrome or chronic kidney disease patients [82].

The blood pressure-lowering effect of sodium restriction is more effective in hypertensive patients than in normotensive patients, and even patients who are already receiving drug therapy can expect an additional 3 mmHg reduction in blood pressure by implementing sodium restriction, making it easier to reduce medication. Additionally, adding weight loss to sodium restriction can lead to an additional effect that is as significant as the blood pressure lowering effect of sodium restriction alone [83]. Moreover, sodium restriction can effectively reduce blood pressure even in patients with resistant hypertension [84]. In addition, excessive sodium intake is known to weaken the effect of renin-angiotensin system blockers [85].

Cardiovascular benefit of sodium reduction

Although there was controversy in some UK Biobank studies [86,87,88], most large-scale cohort studies have shown an positive association between high sodium intake and cardiovascular events [78, 89,90,91]. However, large observational studies have not shown consistency regarding the relationship between low sodium intake and cardiovascular events. A meta-analysis of high-quality prospective cohort studies demonstrated a dose-dependent relationship between sodium intake and cardiovascular events [92, 93]. Whereas, certain large cohort studies, such as the Prospective Urban Rural Epidemiology (PURE) study, have identified a J-curve phenomenon in which an inverse association exists between low sodium intake and cardiovascular events [78, 94,95,96]. This J-curve phenomenon is thought to be hypothesized based on the role of sodium, which is known to play a critical role in normal human physiology [97], and the activation of the renin–angiotensin–aldosterone system, as well as the observed increase in the lipid profile with low sodium intake [64]. Although there has been a debate surrounding the explanation for the J-curve phenomenon, there is a growing consensus that much of the effect can be attributed to methodological artifacts (such as the estimation of sodium intake using spot urine samples) or epidemiological analyses (such as confounders and reverse causality) [98].

Several randomized controlled trials also have conducted to investigate the impact of salt reduction on cardiovascular disease, but the majority of these studies had inadequate sample sizes and durations. According to a previous Cochrane review, the evidence supporting the effectiveness of interventions aimed at reducing dietary salt on cardiovascular events was small [99, 100]. Contrary to these claims, opposing results have also been reported that reducing salt intake is associated with a significant decrease in cardiovascular events [101].. In addition, National Academy of Sciences (NAS) report concluded that reducing dietary sodium intake can prevent cardiovascular events based on a meta-analysis of well-designed relatively long-term trials, including the Trials of Hypertension Prevention (TOHP), and the Trials of Nonpharmacologic Intervention in the Elderly (TONE) [102,103,104]. More recently, a meta-analysis including the Health Professionals Follow-up Study (HPFS), the Nurses’ Health Study (NHS), NHS II, the Prevention of Renal and Vascular End-Stage Disease (PREVEND), TOHP I, and TOHP II trials, which repeatedly conducted 24-hour urine collection as the most appropriate method, reported a dose-dependent and significant association between high sodium intake and risk of cardiovascular events [83, 96, 105,106,107,108]. They reported that daily increment of 1 g in sodium excretion was associated with an 18% increase in cardiovascular events [93]. Table 1 summarizes large observational studies (more than 1000 sample) that have evaluated the association between sodium intake and cardiovascular events using 24-hour urinary sodium excretion [79, 93, 95, 109,110,111,112,113].

Table 1 Major observational studies evaluating the relationship between sodium intake and cardiovascular events through 24-hour urinary sodium excretion
Full size table

Due to the issues of high cost and time associated with conducting large randomized clinical trials (RCTs), relatively cost-effective cluster RCTs have been conducted using a method that compares potassium-rich salt substitutes with regular salt [114,115,116]. At present, the most representative large-scale cluster RCT is the Salt Substitute and Stroke Study (SSaSS) trial, which included 20,995 participants aged 60 years or older with a history of stroke or hypertension in 600 villages in rural China. In the SSaSS trial, the participants who received the salt substitute (75% sodium and 25% potassium) had significantly lower rates of cardiovascular events including death than those who received regular salt (100% sodium) [116]. There may be controversies about the design of the SSaSS trial, such as the absence of a placebo intervention and the inability to confirm whether the benefits in the intervention group were due to potassium supply. However, it cannot be denied that it provided important community-based evidence on low sodium diet.

When considering these pieces of evidence as a whole, it may be difficult to provide conclusive evidence due to challenging barriers. However, there is still controversy over the interpretation of observational study results, studies emphasizing the accurate measurement of sodium intake and intervention studies have demonstrated a positive association between sodium intake and blood pressure, as well as a direct linear association with cardiovascular events. Therefore, at this point, it is necessary to emphasize the daily sodium intake limit (less than 2.0–2.4 g per day) recommended by the WHO and clinical practice guidelines. In addition, reducing salt intake through population-wide interventions is likely to be a cost-effective choice in public health [117].

Sustainability of sodium intake restriction

Despite these beneficial effects, it is quite difficult to continue a low sodium diet [118]. To achieve this, a systematic approach is crucial in accordance with the principle of evaluating the general treatment adherence rate of chronic diseases. In addition to the development and education of medical personnel for team-based approaches and appropriate therapeutic counseling to support individual patient behavioral change, considerations for social or ecological factors related to sodium restriction must also be included [119]. For example, it is known that in most cases, additional sodium beyond the natural sodium found in raw ingredients is supplied during food processing or commercial food sales. Therefore, it is important to reduce processed foods and check the sodium content indicated on food labels [120]. Food labeling can give motivation to consumers choose low sodium products [121]. Additionally, certain labeling practices can encourage manufacturers to reformulate their products to contain less sodium. In order to choose low sodium content, it is important to choose products without additional salt, reduce foods seasoned or pickled with salt or seasonings, use low sodium spices with spicy flavors, choose carefully when eating out, adjust the nutrient content of food, and avoid using sodium at the table. Consultation with a skilled nutritionist on behavior change can be helpful in implementing these methods. If sodium restriction is possible through social or institutional improvements, it can reduce the effort to consciously reduce sodium intake, thus maximizing efficiency [122]. Self-monitoring is crucial in patients’ self-management, particularly for chronic diseases such as diabetes, asthma, and heart failure [123]. The potential benefits of self-monitoring are promising, as literature indicates it may enhance self-management, symptom management, and disease regulation, resulting in fewer complications, improved coping and attitudes towards the illness, realistic goal setting, and an overall better quality of life [124, 125]. Self-blood pressure monitoring, such as home blood pressure, has been shown to improve treatment adherence in hypertension and is actively recommended [5, 126]. For example, when counseling patients on their home blood pressure measurement results, regularly showing patients with a few days of blood pressure increases can help them monitor the effects of sodium intake on blood pressure and can help them understand their salt sensitivity and the blood pressure-lowering effect of sodium restriction, which can have a positive effect on sustained behavior change.

Benefit of high potassium diet

Unlike the controversy surrounding the effects of low sodium intake, there is relatively consistent evidence regarding the blood pressure-lowering and cardiovascular benefits of high potassium intake. The INTERSALT study found that potassium intake was an important independent determinant of blood pressure, independent from sodium intake [127]. In the 10-year follow-up study conducted in the Korean population, which had a relatively low sodium intake of approximately 2500 mg per day, there were concerns regarding the accuracy of the food frequency questionnaire. The study revealed that potassium intake and the Na:K ratio were more reliable predictors of cardiovascular outcomes [128]. The PURE study also reported that as urinary potassium excretion increased, systolic blood pressure decreased, and the rates of mortality and cardiovascular events were decreased [129]. Several meta-analyses have consistently shown similar results. In a meta-analysis comprising 33 randomized controlled trials (N = 2609), data were collected by comparing intervention and control groups in which the only variable was potassium supplementation. This meta-analysis revealed a significant reduction in systolic blood pressure of 3.1 mmHg and diastolic blood pressure of 2.0 mmHg in the groups that received potassium supplementation [130]. Similarly, a more recent meta-analysis conducted in 2013, including 22 randomized controlled trials and 11 cohort studies (N = 1606), found a systolic blood pressure reduction of 3.5 mmHg and diastolic blood pressure reduction of 2.0 mmHg in adults with hypertension who received potassium supplementation. However, this effect was not observed among individuals without hypertension. Furthermore, higher potassium intake was associated with a 24% reduced risk of stroke [131]. Similarly, a meta-analysis examined 10 prospective studies (N = 268,276 participants, 8695 stroke cases) that investigated the relative risks of stroke across three categories of potassium intake or with potassium intake as a continuous variable. This analysis revealed that for every 1 g/day increase in potassium supplementation, there was an 11% reduction in the relative risk of stroke [132]. These cardiovascular beneficial effects of potassium have been consistently observed in meta-analyses, including studies on 24-hour urinary potassium excretion [93].

In a SSaSS trial [116], the group that replaced regular salt with a salt-substitute consisting of 75% sodium chloride and 25% potassium chloride showed a reduced risk of major adverse cardiovascular events (risk ratio 0.87), death from any cause (risk ratio 0.88), death from vascular insult (risk ratio 0.87), nonfatal acute coronary syndrome (risk ratio 0.70), and stroke (risk ratio 0.86). It is important to note that the SSaSS trial excluded patients who were at risk of hyperkalemia, such as those on potassium-sparing diuretics, taking potassium supplements, or with advanced chronic kidney disease. This exclusion raises concerns about the potential risk of hyperkalemia in this specific population. In individuals with chronic kidney disease, the prevention and management of hyperkalemia can result in significant medical expenses and burdens on the healthcare system [133, 134]. Further research is required to determine the long-term effects of potassium supplementation in patients with chronic kidney disease.

DASH diet and sodium potassium ratio

Potassium is abundant in vegetables, fruits, potatoes, sweet potatoes, and legumes and is an important component of the dietary approaches to stop hypertension (DASH). The recommended daily intake of potassium in the US is 4.7 g, while the WHO recommends a daily intake of 3.5 g [135, 136]. The DASH diet is a standard diet for lowering blood pressure in hypertensive patients. It showed a blood pressure lowering effect of 11 mmHg and 3 mmHg in hypertensive patients and normal individuals, respectively, and the effect is independent of sodium intake, with additional blood pressure-lowering effects expected when combined with a low sodium diet [137]. The DASH diet is widely recognized as the most effective dietary pattern for lowering blood pressure. Because the DASH diet is high in fruits, vegetables, and low-fat dairy products, it provides a means to enhance intake of potassium, calcium, magnesium, and fiber [138]. Potassium is mainly related to fruit and vegetable intake. The DASH diet typically provides 4.7 g of potassium per day, which is the same as the recommended daily intake of potassium [139]. A low sodium diet and DASH diet recommended for patients with hypertension can be summarized as a diet that reduces sodium and increases potassium, in other words, a diet that reduces the sodium-potassium ratio. It can be inferred that the sodium-potassium ratio may be more important in actual situations than the individual effects of sodium or potassium, which is consistent with the theoretical basis for sodium reabsorption discussed earlier. Although there are no established recommendations for the sodium-potassium ratio, WHO recommends a ratio of 1.0 based on mol units [59].

Conclusions

In conclusion, increased sodium intake has been shown to have a positive correlation with blood pressure and cardiovascular events, especially in hypertensive population, in past studies conducted in various ways with sound methodology, particularly accurate measurements of salt intake. Reflecting this evidence, efforts to reduce sodium intake are already underway in many countries [140], and many clinical guidelines recommend reducing sodium intake [5, 62, 138, 141]. In addition, a high potassium diet also plays an important role in preventing and controlling hypertension and cardiovascular diseases. To achieve effective blood pressure control and reducing cardiovascular events, it is important to implement a low sodium diet and a high potassium diet simultaneously to maintain a low sodium-potassium ratio in the diet.

Availability of data and materials

Not applicable.

Abbreviations

ASDN:

aldosterone-sensitive distal nephron

DCT:

distal convoluted tubule

CNT:

connecting tubule

CCD:

cortical collecting duct

NCC:

sodium-chloride cotransporter

ENaC:

epithelial sodium channel

ROMK:

renal outer medullary K+ channel

BK:

big-K+ channels

WNK:

with-no-lysine (K) kinases

SPAK:

Ste-20-related proline alanine-rich protein kinase

OSR1:

oxidative stress-responsive kinase 1

WHO:

World Health Organization

AHA:

American Heart Association

NAS:

National Academy of Sciences

TOHP:

the Trials of Hypertension Prevention

TONE:

the Trials of Nonpharmacologic Intervention in the Elderly

HPFS:

the Health Professionals Follow-up Study

NHS:

the Nurses’ Health Study

PREVEND:

the Prevention of Renal and Vascular End-Stage Disease

RCT:

randomized clinical trial

SSaSS:

the Salt Substitute and Stroke Study

INTERSALT:

the International Cooperative Study on Salt, Other Factors, and Blood

PURE:

the Prospective Urban Rural Epidemiology

DASH:

the dietary approaches to stop hypertension.

References

  1. Organization WH. A global brief on hypertension: silent killer, global public health crisis: world health day 2013. In: World Health Organization; 2013.

    Google Scholar 

  2. Kim HC, Cho SMJ, Lee H, Lee HH, Baek J, Heo JE. Korea hypertension fact sheet 2020: analysis of nationwide population-based data. Clin Hypertens. 2021;27(1):8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80.

    Article  Google Scholar 

  4. Kim HL, Lee EM, Ahn SY, Kim KI, Kim HC, Kim JH, et al. The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension. Clin Hypertens. 2023;29(1):11.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lee HY, Shin J, Kim GH, Park S, Ihm SH, Kim HC, et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25:20.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Walser M. Phenomenological analysis of renal regulation of sodium and potassium balance. Kidney Int. 1985;27(6):837–41.

    Article  PubMed  CAS  Google Scholar 

  7. Bie P. Mechanisms of sodium balance: total body sodium, surrogate variables, and renal sodium excretion. Am J Phys Regul Integr Comp Phys. 2018;315(5):R945–r962.

    CAS  Google Scholar 

  8. Bie P, Wamberg S, Kjolby M. Volume natriuresis vs. pressure natriuresis. Acta Physiol Scand. 2004;181(4):495–503.

    Article  PubMed  CAS  Google Scholar 

  9. Duda K, Majerczak J, Nieckarz Z, Heymsfield SB, Zoladz JA. Chapter 1 - Human Body Composition and Muscle Mass. In: Zoladz JA, editor. Muscle and exercise physiology. Academic Press; 2019. p. 3–26.

    Google Scholar 

  10. van Westing AC, Küpers LK, Geleijnse JM. Diet and Kidney Function: a Literature Review. Curr Hypertens Rep. 2020;22(2):14.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Guthrie D, Yucha C. Urinary concentration and dilution. Nephrol Nurs J. 2004;31(3):297–301. quiz 302–293

    PubMed  Google Scholar 

  12. Natochin YV, Golosova DV. Vasopressin receptor subtypes and renal sodium transport. Vitam Horm. 2020;113:239–58.

    Article  PubMed  CAS  Google Scholar 

  13. Bernal A, Zafra MA, Simón MJ, Mahía J. Sodium Homeostasis, a Balance Necessary for Life. Nutrients. 2023;15(2):395.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Girardin E, Caverzasio J, Iwai J, Bonjour JP, Muller AF, Grandchamp A. Pressure natriuresis in isolated kidneys from hypertension-prone and hypertension-resistant rats (Dahl rats). Kidney Int. 1980;18(1):10–9.

    Article  PubMed  CAS  Google Scholar 

  15. Felder RA, White MJ, Williams SM, Jose PA. Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens. 2013;22(1):65–76.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Titze J, Dahlmann A, Lerchl K, Kopp C, Rakova N, Schröder A, et al. Spooky sodium balance. Kidney Int. 2014;85(4):759–67.

    Article  PubMed  CAS  Google Scholar 

  17. Clemmer JS, Pruett WA, Coleman TG, Hall JE, Hester RL. Mechanisms of blood pressure salt sensitivity: new insights from mathematical modeling. Am J Phys Regul Integr Comp Phys. 2017;312(4):R451–r466.

    Google Scholar 

  18. Elijovich F, Weinberger MH, Anderson CA, Appel LJ, Bursztyn M, Cook NR, et al. Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. Hypertension. 2016;68(3):e7–e46.

    Article  PubMed  CAS  Google Scholar 

  19. Koomans HA, Roos JC, Boer P, Geyskes GG, Mees EJ. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension. 1982;4(2):190–7.

    Article  PubMed  CAS  Google Scholar 

  20. Titze J, Shakibaei M, Schafflhuber M, Schulze-Tanzil G, Porst M, Schwind KH, et al. Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin. Am J Physiol Heart Circ Physiol. 2004;287(1):H203–8.

    Article  PubMed  CAS  Google Scholar 

  21. Rossitto G, Mary S, Chen JY, Boder P, Chew KS, Neves KB, et al. Tissue sodium excess is not hypertonic and reflects extracellular volume expansion. Nat Commun. 2020;11(1):4222.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Bräxmeyer DL, Keyes JL. The pathophysiology of potassium balance. Crit Care Nurse. 1996;16(5):59–71. quiz 72–53

    Article  PubMed  Google Scholar 

  23. Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis. Adv Physiol Educ. 2016;40(4):480–90.

    Article  PubMed  Google Scholar 

  24. Staruschenko A. Beneficial Effects of High Potassium: Contribution of Renal Basolateral K(+) Channels. Hypertension. 2018;71(6):1015–22.

    Article  PubMed  CAS  Google Scholar 

  25. Rodrigues SL, Baldo MP, Machado RC, Forechi L, Molina Mdel C, Mill JG. High potassium intake blunts the effect of elevated sodium intake on blood pressure levels. J Am Soc Hypertens. 2014;8(4):232–8.

    Article  PubMed  CAS  Google Scholar 

  26. Giebisch G. Renal potassium transport: mechanisms and regulation. Am J Physiol Renal Physiol. 1998;274(5):F817–33.

    Article  CAS  Google Scholar 

  27. Gumz ML, Rabinowitz L, Wingo CS. An integrated view of potassium homeostasis. N Engl J Med. 2015;373(1):60–72.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Roy A, Al-bataineh MM, Pastor-Soler NM. Collecting duct intercalated cell function and regulation. Clin J Am Soc Nephrol. 2015;10(2):305.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Wade JB, Fang L, Coleman RA, Liu J, Grimm PR, Wang T, et al. Differential regulation of ROMK (Kir1.1) in distal nephron segments by dietary potassium. Am J Physiol Renal Physiol. 2011;300(6):F1385–93.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Gamba G. Molecular biology of distal nephron sodium transport mechanisms. Kidney Int. 1999;56(4):1606–22.

    Article  PubMed  CAS  Google Scholar 

  31. Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA. Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest. 1999;104(7):R19–23.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Rieg T, Vallon V, Sausbier M, Sausbier U, Kaissling B, Ruth P, et al. The role of the BK channel in potassium homeostasis and flow-induced renal potassium excretion. Kidney Int. 2007;72(5):566–73.

    Article  PubMed  CAS  Google Scholar 

  33. Wei KY, Gritter M, Vogt L, de Borst MH, Rotmans JI, Hoorn EJ. Dietary potassium and the kidney: lifesaving physiology. Clin Kidney J. 2020;13(6):952–68.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Gumz ML, Rabinowitz L, Wingo CS. An Integrated View of Potassium Homeostasis. N Engl J Med. 2015;373(1):60–72.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Zhang C, Wang L, Zhang J, Su XT, Lin DH, Scholl UI, et al. KCNJ10 determines the expression of the apical Na-Cl cotransporter (NCC) in the early distal convoluted tubule (DCT1). Proc Natl Acad Sci U S A. 2014;111(32):11864–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Su X-T, Zhang C, Wang L, Gu R, Lin D-H, Wang W-H. Disruption of KCNJ10 (Kir4. 1) stimulates the expression of ENaC in the collecting duct. Am J Physiol Renal Physiol. 2016;310(10):F985–93.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Cuevas CA, Su XT, Wang MX, Terker AS, Lin DH, McCormick JA, et al. Potassium Sensing by Renal Distal Tubules Requires Kir4.1. J Am Soc Nephrol. 2017;28(6):1814–25.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Wang MX, Cuevas CA, Su XT, Wu P, Gao ZX, Lin DH, et al. Potassium intake modulates the thiazide-sensitive sodium-chloride cotransporter (NCC) activity via the Kir4.1 potassium channel. Kidney Int. 2018;93(4):893–902.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Hennings JC, Andrini O, Picard N, Paulais M, Huebner AK, Cayuqueo IK, et al. The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. J Am Soc Nephrol. 2017;28(1):209–17.

    Article  PubMed  CAS  Google Scholar 

  40. Bazúa-Valenti S, Chávez-Canales M, Rojas-Vega L, González-Rodríguez X, Vázquez N, Rodríguez-Gama A, et al. The Effect of WNK4 on the Na+-Cl- Cotransporter Is Modulated by Intracellular Chloride. J Am Soc Nephrol. 2015;26(8):1781–6.

    Article  PubMed  Google Scholar 

  41. Castañeda-Bueno M, Cervantes-Perez LG, Rojas-Vega L, Arroyo-Garza I, Vázquez N, Moreno E, et al. Modulation of NCC activity by low and high K(+) intake: insights into the signaling pathways involved. Am J Physiol Ren Physiol. 2014;306(12):F1507–19.

    Article  Google Scholar 

  42. Yang YS, Xie J, Yang SS, Lin SH, Huang CL. Differential roles of WNK4 in regulation of NCC in vivo. Am J Physiol Ren Physiol. 2018;314(5):F999–f1007.

    Article  CAS  Google Scholar 

  43. Terker AS, Zhang C, McCormick JA, Lazelle RA, Zhang C, Meermeier NP, et al. Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride. Cell Metab. 2015;21(1):39–50.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Hoorn EJ, Gritter M, Cuevas CA, Fenton RA. Regulation of the renal NaCl cotransporter and its role in potassium homeostasis. Physiol Rev. 2020;100(1):321–56.

    Article  PubMed  CAS  Google Scholar 

  45. Jensen IS, Larsen CK, Leipziger J, Sørensen MV. Na(+) dependence of K(+) -induced natriuresis, kaliuresis and Na(+) /Cl(-) cotransporter dephosphorylation. Acta Physiol (Oxford). 2016;218(1):49–61.

    Article  CAS  Google Scholar 

  46. Sorensen MV, Grossmann S, Roesinger M, Gresko N, Todkar AP, Barmettler G, et al. Rapid dephosphorylation of the renal sodium chloride cotransporter in response to oral potassium intake in mice. Kidney Int. 2013;83(5):811–24.

    Article  PubMed  CAS  Google Scholar 

  47. Shoda W, Nomura N, Ando F, Mori Y, Mori T, Sohara E, et al. Calcineurin inhibitors block sodium-chloride cotransporter dephosphorylation in response to high potassium intake. Kidney Int. 2017;91(2):402–11.

    Article  PubMed  CAS  Google Scholar 

  48. Pearce D, Manis AD, Nesterov V, Korbmacher C. Regulation of distal tubule sodium transport: mechanisms and roles in homeostasis and pathophysiology. Pflug Arch Eur J Physiol. 2022;474(8):869–84.

    Article  CAS  Google Scholar 

  49. Yang LE, Sandberg MB, Can AD, Pihakaski-Maunsbach K, McDonough AA. Effects of dietary salt on renal Na+ transporter subcellular distribution, abundance, and phosphorylation status. Am J Physiol Ren Physiol. 2008;295(4):F1003–16.

    Article  CAS  Google Scholar 

  50. van der Lubbe N, Moes AD, Rosenbaek LL, Schoep S, Meima ME, Danser AH, et al. K+-induced natriuresis is preserved during Na+ depletion and accompanied by inhibition of the Na+-Cl- cotransporter. Am J Physiol Ren Physiol. 2013;305(8):F1177–88.

    Article  Google Scholar 

  51. Terker AS, Zhang C, Erspamer KJ, Gamba G, Yang CL, Ellison DH. Unique chloride-sensing properties of WNK4 permit the distal nephron to modulate potassium homeostasis. Kidney Int. 2016;89(1):127–34.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  52. Huang CL, Cheng CJ. A unifying mechanism for WNK kinase regulation of sodium-chloride cotransporter. Pflugers Arch. 2015;467(11):2235–41.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Fujita T, Ando K. Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. Hypertension. 1984;6(2 Pt 1):184–92.

    Article  PubMed  CAS  Google Scholar 

  54. Wilson DK, Sica DA, Miller SB. Effects of potassium on blood pressure in salt-sensitive and salt-resistant black adolescents. Hypertension. 1999;34(2):181–6.

    Article  PubMed  CAS  Google Scholar 

  55. Walkowska A, Kuczeriszka M, Sadowski J, Olszyñski KH, Dobrowolski L, Červenka L, et al. High salt intake increases blood pressure in normal rats: putative role of 20-HETE and no evidence on changes in renal vascular reactivity. Kidney Blood Press Res. 2015;40(3):323–34.

    Article  PubMed  CAS  Google Scholar 

  56. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ (Clin Res ed). 1988;297(6644):319–28.

    Article  Google Scholar 

  57. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, et al. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1995;1(10):1009–16.

    Article  PubMed  CAS  Google Scholar 

  58. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3(12):e003733.

    Article  PubMed  PubMed Central  Google Scholar 

  59. WHO Guidelines Approved by the Guidelines Review Committee. Guideline: Sodium Intake for Adults and Children. Geneva: World Health Organization Copyright © 2012: World Health Organization; 2012.

    Google Scholar 

  60. Snetselaar LG, de Jesus JM, DeSilva DM, Stoody EE. Dietary Guidelines for Americans, 2020-2025: Understanding the Scientific Process, Guidelines, and Key Recommendations. Nutr Today. 2021;56(6):287–95.

    Article  PubMed  PubMed Central  Google Scholar 

  61. EFSA Panel on Nutrition NF, Allergens F, Turck D, Castenmiller J, de Henauw S, Hirsch-Ernst K-I, et al. Dietary reference values for sodium. EFSA J. 2019;17(9):e05778.

    Google Scholar 

  62. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021–104.

    Article  PubMed  Google Scholar 

  63. Graudal N, Hubeck-Graudal T, Jürgens G, Taylor RS. Dose-response relation between dietary sodium and blood pressure: a meta-regression analysis of 133 randomized controlled trials. Am J Clin Nutr. 2019;109(5):1273–8.

    Article  PubMed  Google Scholar 

  64. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev. 2020;12(12):Cd004022.

    PubMed  Google Scholar 

  65. Cappuccio FP, Beer M, Strazzullo P. Population dietary salt reduction and the risk of cardiovascular disease. A scientific statement from the European Salt Action Network. Nutr Metab Cardiovasc Dis. 2018;29(2):107–14.

    Article  PubMed  CAS  Google Scholar 

  66. He FJ, Campbell NRC, Ma Y, MacGregor GA, Cogswell ME, Cook NR. Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health. Int J Epidemiol. 2018;47(6):1784–95.

    Article  PubMed  PubMed Central  Google Scholar 

  67. He FJ, Campbell NRC, Woodward M, MacGregor GA. Salt reduction to prevent hypertension: the reasons of the controversy. Eur Heart J. 2021;42(25):2501–5.

    Article  PubMed  Google Scholar 

  68. He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ (Clin Res ed). 2013;346:f1325.

    Google Scholar 

  69. Huang L, Trieu K, Yoshimura S, Neal B, Woodward M, Campbell NRC, et al. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials. BMJ (Clin Res ed). 2020;368:m315.

    Google Scholar 

  70. Olde Engberink RHG, van den Hoek TC, van Noordenne ND, van den Born BH, Peters-Sengers H, Vogt L. Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk. Circulation. 2017;136(10):917–26.

    Article  PubMed  CAS  Google Scholar 

  71. McLean RM, Farmer VL, Nettleton A, Cameron CM, Cook NR, Campbell NRC. Assessment of dietary sodium intake using a food frequency questionnaire and 24-hour urinary sodium excretion: a systematic literature review. J Clin Hypertens (Greenwich, Conn). 2017;19(12):1214–30.

    Article  Google Scholar 

  72. McLean RM, Farmer VL, Nettleton A, Cameron CM, Cook NR, Woodward M, et al. Twenty-Four-Hour Diet recall and Diet records compared with 24-hour urinary excretion to predict an individual's sodium consumption: A Systematic Review. J Clin Hypertens (Greenwich, Conn). 2018;20(10):1360–76.

    Article  Google Scholar 

  73. Lucko AM, Doktorchik C, Woodward M, Cogswell M, Neal B, Rabi D, et al. Percentage of ingested sodium excreted in 24-hour urine collections: A systematic review and meta-analysis. J Clin Hypertens (Greenwich, Conn). 2018;20(9):1220–9.

    Article  Google Scholar 

  74. Lerchl K, Rakova N, Dahlmann A, Rauh M, Goller U, Basner M, et al. Agreement between 24-hour salt ingestion and sodium excretion in a controlled environment. Hypertension. 2015;66(4):850–7.

    Article  PubMed  CAS  Google Scholar 

  75. Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16(2):97–103.

    Article  PubMed  CAS  Google Scholar 

  76. Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol. 1993;20(1):7–14.

    Article  PubMed  CAS  Google Scholar 

  77. Brown IJ, Dyer AR, Chan Q, Cogswell ME, Ueshima H, Stamler J, et al. Estimating 24-hour urinary sodium excretion from casual urinary sodium concentrations in Western populations: the INTERSALT study. Am J Epidemiol. 2013;177(11):1180–92.

    Article  PubMed  PubMed Central  Google Scholar 

  78. O'Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371(7):612–23.

    Article  PubMed  Google Scholar 

  79. Cook NR, Appel LJ, Whelton PK. Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. J Am Coll Cardiol. 2016;68(15):1609–17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  80. Huang L, Crino M, Wu JH, Woodward M, Barzi F, Land MA, et al. Mean population salt intake estimated from 24-h urine samples and spot urine samples: a systematic review and meta-analysis. Int J Epidemiol. 2016;45(1):239–50.

    Article  PubMed  Google Scholar 

  81. Cappuccio FP, Sever PS. The importance of a valid assessment of salt intake in individuals and populations. A scientific statement of the British and Irish Hypertension Society. J Hum Hypertens. 2019;33(5):345–8.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Suckling RJ, He FJ, Markandu ND, MacGregor GA. Modest Salt Reduction Lowers Blood Pressure and Albumin Excretion in Impaired Glucose Tolerance and Type 2 Diabetes Mellitus: A Randomized Double-Blind Trial. Hypertension. 2016;67(6):1189–95.

    Article  PubMed  CAS  Google Scholar 

  83. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157(6):657–67.

    Article  Google Scholar 

  84. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54(3):475–81.

    Article  PubMed  CAS  Google Scholar 

  85. Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012;23(1):165–73.

    Article  PubMed  CAS  Google Scholar 

  86. Welsh CE, Welsh P, Jhund P, Delles C, Celis-Morales C, Lewsey JD, et al. Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease. Hypertension. 2019;73(6):1202–9.

    Article  PubMed  CAS  Google Scholar 

  87. Zanetti D, Bergman H, Burgess S, Assimes TL, Bhalla V, Ingelsson E. Urinary Albumin, Sodium, and Potassium and Cardiovascular Outcomes in the UK Biobank: Observational and Mendelian Randomization Analyses. Hypertension. 2020;75(3):714–22.

    Article  PubMed  CAS  Google Scholar 

  88. Elliott P, Muller DC, Schneider-Luftman D, Pazoki R, Evangelou E, Dehghan A, et al. Estimated 24-Hour Urinary Sodium Excretion and Incident Cardiovascular Disease and Mortality Among 398 628 Individuals in UK Biobank. Hypertension. 2020;76(3):683–91.

    Article  PubMed  CAS  Google Scholar 

  89. Mente A, O'Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet (London, England). 2016;388(10043):465–75.

    Article  PubMed  CAS  Google Scholar 

  90. O'Donnell M, Mente A, Rangarajan S, McQueen MJ, O'Leary N, Yin L, et al. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study. BMJ (Clin Res ed). 2019;364:l772.

    Google Scholar 

  91. Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129(9):981–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  92. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ (Clin Res ed). 2009;339:b4567.

    Article  Google Scholar 

  93. Ma Y, He FJ, Sun Q, Yuan C, Kieneker LM, Curhan GC, et al. 24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk. N Engl J Med. 2022;386(3):252–63.

    Article  PubMed  CAS  Google Scholar 

  94. Mente A, O'Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018;392(10146):496–506.

    Article  PubMed  Google Scholar 

  95. Mills KT, Chen J, Yang W, Appel LJ, Kusek JW, Alper A, et al. Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease. Jama. 2016;315(20):2200–10.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Kieneker LM, Eisenga MF, Gansevoort RT, de Boer RA, Navis G, Dullaart RPF, et al. Association of Low Urinary Sodium Excretion With Increased Risk of Stroke. Mayo Clin Proc. 2018;93(12):1803–9.

    Article  PubMed  CAS  Google Scholar 

  97. Heaney RP. Sodium: how and how not to set a nutrient intake recommendation. Am J Hypertens. 2013;26(10):1194–7.

    Article  PubMed  Google Scholar 

  98. Cook NR, He FJ, MacGregor GA, Graudal N. Sodium and health-concordance and controversy. BMJ (Clin Res ed). 2020;369:m2440.

    Google Scholar 

  99. Adler AJ, Taylor F, Martin N, Gottlieb S, Taylor RS, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014;2014(12):Cd009217.

    PubMed  PubMed Central  Google Scholar 

  100. Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens. 2011;24(8):843–53.

    Article  PubMed  CAS  Google Scholar 

  101. He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet (London, England). 2011;378(9789):380–2.

    Article  PubMed  Google Scholar 

  102. National Academies of Sciences E, Medicine, Health, Medicine D, Food, Nutrition B, Committee to Review the Dietary Reference Intakes for S, Potassium. The National Academies Collection: Reports funded by National Institutes of Health. In: Oria M, Harrison M, Stallings VA, editors. Dietary Reference Intakes for Sodium and Potassium. Washington (DC): National Academies Press (US) Copyright 2019 by the National Academy of Sciences. All rights reserved; 2019.

    Google Scholar 

  103. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ (Clin Res ed). 2007;334(7599):885–8.

    Article  Google Scholar 

  104. Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S, Lacy CR. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med. 2001;161(5):685–93.

    Article  PubMed  CAS  Google Scholar 

  105. Bao Y, Bertoia ML, Lenart EB, Stampfer MJ, Willett WC, Speizer FE, et al. Origin, Methods, and Evolution of the Three Nurses’ Health Studies. Am J Public Health. 2016;106(9):1573–81.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Sun Q, Bertrand KA, Franke AA, Rosner B, Curhan GC, Willett WC. Reproducibility of urinary biomarkers in multiple 24-h urine samples. Am J Clin Nutr. 2017;105(1):159–68.

    Article  PubMed  CAS  Google Scholar 

  107. Yuan C, Spiegelman D, Rimm EB, Rosner BA, Stampfer MJ, Barnett JB, et al. Relative Validity of Nutrient Intakes Assessed by Questionnaire, 24-Hour Recalls, and Diet Records as Compared With Urinary Recovery and Plasma Concentration Biomarkers: Findings for Women. Am J Epidemiol. 2018;187(5):1051–63.

    Article  PubMed  Google Scholar 

  108. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. Jama 1992, 267(9):1213–1220.

  109. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. Jama. 2011;305(17):1777–85.

    Article  PubMed  CAS  Google Scholar 

  110. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011;34(4):861–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  111. Joosten MM, Gansevoort RT, Mukamal KJ, Lambers Heerspink HJ, Geleijnse JM, Feskens EJ, et al. Sodium excretion and risk of developing coronary heart disease. Circulation. 2014;129(10):1121–8.

    Article  PubMed  CAS  Google Scholar 

  112. Singer P, Cohen H, Alderman M. Assessing the associations of sodium intake with long-term all-cause and cardiovascular mortality in a hypertensive cohort. Am J Hypertens. 2015;28(3):335–42.

    Article  PubMed  CAS  Google Scholar 

  113. Vuori MA, Harald K, Jula A, Valsta L, Laatikainen T, Salomaa V, et al. 24-h urinary sodium excretion and the risk of adverse outcomes. Ann Med. 2020;52(8):488–96.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  114. Chang HY, Hu YW, Yue CS, Wen YW, Yeh WT, Hsu LS, et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr. 2006;83(6):1289–96.

    Article  PubMed  CAS  Google Scholar 

  115. Bernabe-Ortiz A, Sal YRVG, Ponce-Lucero V, Cárdenas MK, Carrillo-Larco RM, Diez-Canseco F, et al. Effect of salt substitution on community-wide blood pressure and hypertension incidence. Nat Med. 2020;26(3):374–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  116. Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J, et al. Effect of Salt Substitution on Cardiovascular Events and Death. N Engl J Med. 2021;385(12):1067–77.

    Article  PubMed  CAS  Google Scholar 

  117. Wang G, Labarthe D. The cost-effectiveness of interventions designed to reduce sodium intake. J Hypertens. 2011;29(9):1693–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  118. Whelton PK, Kumanyika SK, Cook NR, Cutler JA, Borhani NO, Hennekens CH, et al. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. Am J Clin Nutr. 1997;65(2 Suppl):652s–60s.

    Article  PubMed  CAS  Google Scholar 

  119. Ihm SH, Kim KI, Lee KJ, Won JW, Na JO, Rha SW, et al. Interventions for Adherence Improvement in the Primary Prevention of Cardiovascular Diseases: Expert Consensus Statement. Korean Circ J. 2022;52(1):1–33.

    Article  PubMed  CAS  Google Scholar 

  120. Anderson CA, Appel LJ, Okuda N, Brown IJ, Chan Q, Zhao L, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc. 2010;110(5):736–45.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  121. Cobb LK, Appel LJ, Anderson CA. Strategies to reduce dietary sodium intake. Curr Treat Options Cardiovasc Med. 2012;14(4):425–34.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Appel L, Miller E. Promoting lifestyle modification in the office setting. In: Hypertension: hot topics. Philadelphia: Hanley & Belfus, Inc; 2004. p. 155–63.

    Google Scholar 

  123. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177–87.

    Article  PubMed  Google Scholar 

  124. Wilde MH, Garvin S. A concept analysis of self-monitoring. J Adv Nurs. 2007;57(3):339–50.

    Article  PubMed  Google Scholar 

  125. Richard AA, Shea K. Delineation of self-care and associated concepts. J Nurs Scholarsh. 2011;43(3):255–64.

    PubMed  Google Scholar 

  126. Jo SH, Kim SA, Park KH, Kim HS, Han SJ, Park WJ. Self-blood pressure monitoring is associated with improved awareness, adherence, and attainment of target blood pressure goals: Prospective observational study of 7751 patients. J Clin Hypertens (Greenwich, Conn). 2019;21(9):1298–304.

    Article  Google Scholar 

  127. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Res Group BMJ (Clin Res Ed). 1996;312(7041):1249–53.

    Article  CAS  Google Scholar 

  128. Kwon YJ, Lee HS, Park G, Lee JW. Association between dietary sodium, potassium, and the sodium-to-potassium ratio and mortality: A 10-year analysis. Front Nutr. 2022;9:1053585.

    Article  PubMed  PubMed Central  Google Scholar 

  129. Miller V, Yusuf S, Chow CK, Dehghan M, Corsi DJ, Lock K, et al. Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet Glob Health. 2016;4(10):e695–703.

    Article  PubMed  Google Scholar 

  130. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. Jama. 1997;277(20):1624–32.

    Article  PubMed  CAS  Google Scholar 

  131. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ (Clin Res ed). 2013;346:f1378.

    Google Scholar 

  132. Larsson SC, Orsini N, Wolk A. Dietary potassium intake and risk of stroke: a dose-response meta-analysis of prospective studies. Stroke. 2011;42(10):2746–50.

    Article  PubMed  CAS  Google Scholar 

  133. Gritter M, Wouda RD, Yeung SMH, Wieërs MLA, Geurts F, de Ridder MAJ, et al. Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD. J Am Soc Nephrol. 2022;33(9):1779–89.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  134. Mu F, Betts KA, Woolley JM, Dua A, Wang Y, Zhong J, et al. Prevalence and economic burden of hyperkalemia in the United States Medicare population. Curr Med Res Opin. 2020;36(8):1333–41.

    Article  PubMed  CAS  Google Scholar 

  135. Food Labeling. Revision of the Nutrition and Supplement Facts Labels. Final Rule Fed Regist. 2016;81(103):33741–999.

    Google Scholar 

  136. Drewnowski A, Rehm CD, Maillot M, Mendoza A, Monsivais P. The feasibility of meeting the WHO guidelines for sodium and potassium: a cross-national comparison study. BMJ Open. 2015;5(3):e006625.

    Article  PubMed  PubMed Central  Google Scholar 

  137. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336(16):1117–24.

    Article  PubMed  CAS  Google Scholar 

  138. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115.

    PubMed  CAS  Google Scholar 

  139. Lee CH, Shin J. Effect of low sodium and high potassium diet on lowering blood pressure. J Korean Med Assoc. 2022;65(6):368–76.

    Article  Google Scholar 

  140. He FJ, Pombo-Rodrigues S, Macgregor GA. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open. 2014;4(4):e004549.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

None.

Funding

This study was sponsored by Korean Society of Hypertension, South Korea.

Author information

Author notes

  1. Byung Sik Kim and Mi-Yeon Yu contributed equally to this work.

Authors and Affiliations

  1. Division of Cardiology, Department of Internal Medicine, Hanyang University Guri Hospital, Guri, South Korea

    Byung Sik Kim

  2. Division of Nephrology, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea

    Mi-Yeon Yu

  3. Division of Cardiology, Department of Internal Medicine, Hanyang University Medical Center, Hanyang University College of Medicine, 222, Wangsimni-ro, Sungdong-gu, Seoul, 04763, South Korea

    Jinho Shin

Authors
  1. Byung Sik Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mi-Yeon Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jinho Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BSK was responsible for drafting the article, and was a major contributor in writing the manuscript. MYY were responsible for manuscript preparation. JS was responsible for conceptualization, study design, and manuscript preparation. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jinho Shin.

Ethics declarations

Ethics approval and consent to participate 

Not applicable.

Consent for publication

Not applicable.

Competing interests

There are no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, B.S., Yu, MY. & Shin, J. Effect of low sodium and high potassium diet on lowering blood pressure and cardiovascular events. Clin Hypertens 30, 2 (2024). https://doi.org/10.1186/s40885-023-00259-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40885-023-00259-0

Keywords

Clinical Hypertension

ISSN: 2056-5909

Contact us